Newsroom

For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org​​​​​​​ or 202-536-2285.

• STATEMENT ON NEW JOHNSON & JOHNSON RESTRICTIONS ON 340B ACCESS

  February 22, 2023 in 340B Health News Releases

• UPDATED: STATEMENT ON BAYER AND EMD SERONO RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  February 01, 2023 in 340B Health News Releases

• STATEMENT ON THIRD CIRCUIT APPEALS COURT DECISION ON DRUGMAKERS’ 340B RESTRICTIONS

  January 30, 2023 in 340B Health News Releases

• 340B HEALTH BOARD ELECTS THREE NEW MEMBERS

  January 19, 2023 in 340B Health News Releases

• STATEMENT REGARDING WALL STREET JOURNAL STORY

  December 20, 2022 in 340B Health News Releases

• STATEMENT ON BIOGEN RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  December 13, 2022 in 340B Health News Releases

• STATEMENT ON THE RETIREMENT OF SENIOR VP OF COMMUNICATIONS RICHARD SORIAN

  December 07, 2022 in 340B Health News Releases

• 30 Years Of 340B: Preserving The Health Care Safety Net

  December 07, 2022 in 340B in the News

• STATEMENT ON FINAL 2023 MEDICARE OPPS RULE

  November 01, 2022 in 340B Health News Releases

• Drug discount program vital to hospital care

  October 30, 2022 in 340B in the News

• MERCK REFERRED FOR PENALTIES FOR REFUSAL TO FOLLOW FEDERAL LAW ON 340B PRICING

  October 21, 2022 in 340B Health News Releases

• HRSA DIRECTS ABBVIE AND AMGEN TO RESTORE 340B PRICING TO SAFETY-NET HOSPITALS

  October 17, 2022 in 340B Health News Releases